1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M


1 Year 1Y

5 Years 5Y

About Inari Medical Inc

Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari has developed two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The company purpose-built its products for the specific characteristics of the venous system and the treatment of the two distinct manifestations of venous thromboembolism, or VTE: deep vein thrombosis and pulmonary embolism. The ClotTriever system is 510(k)-cleared by the FDA and CE Mark approved for the treatment of deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA and CE Mark approved for the treatment of pulmonary embolism and clot in transit in the right atrium.


Inari Medical, Inc. (NARI) CEO Bill Hoffman on Q2 2022 Results - Earnings Call Transcript
Aug 04, 2022 03:18am

Inari Medical, Inc. (NASDAQ:NASDAQ:NARI) Q2 2022 Earnings Conference Call August 03, 2022, 05:00 PM ET Company Participants Caroline Corner - IR Bill Hoffman - President and CEO Mitch Hill…

Source:Seeking Alpha
Inari Medical, Inc. (NARI) Q2 2022 Earnings Call Transcript
Aug 04, 2022 02:00am

NARI earnings call for the period ending June 30, 2022.

Source:The Motley Fool
Inari Medical stock falls as Q2 sees net loss; COO to helm company next year
Aug 03, 2022 22:10pm

Inari Medical (NARI) stock fell ~6% post market after the company reported a net loss of -10.19M in Q2, compared to a net income of $4.07M in the prior year period.Inari said in a…

Source:Seeking Alpha
Inari Medical names Drew Hykes as CEO (NASDAQ:NARI)
Aug 03, 2022 21:06pm

Inari Medical (NARI) has announced leadership succession plan, with COO Drew Hykes replacing Bill Hoffman as the new CEO, effective January 1, 2023.Mr

Source:Seeking Alpha
Inari Medical GAAP EPS of -$0.19 beats by $0.04, revenue of $92.7M beats by $4.9M
Aug 03, 2022 20:44pm

Inari Medical press release (NARI): Q2 GAAP EPS of -$0.19 beats by $0.04.Revenue of $92.7M (+46.1% Y/Y) beats by $4.9M.Shares -6%.For the full year 2022, we are reaffirming our…

Source:Seeking Alpha
Inari Medical: Fundamentals Soft, But Near-Term Upside Capture
Jul 22, 2022 16:23pm

Inari Medical has curled up since May, with the share catching a bid and strengthening against key benchmarks. Click here to read more.

Source:Seeking Alpha
Inari Medical to Announce Second Quarter 2022 Financial Results
Jul 18, 2022 20:01pm

IRVINE, Calif., July 18, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today that it will release its second quarter 2022 financial results on Wednesday, August 3, 2022. In conjunction with the release, Inari will host a conference call and webcast at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time to discuss its financial results and recent highlights.

NARI stock higher as Piper Sandler issues Overweight rating (NASDAQ:NARI)
Jun 21, 2022 17:47pm

Medical device company Inari Medical (NARI) is trading higher on Tuesday after Piper Sandler initiated its coverage with an Overweight recommendation citing multiple growth drivers for…

Source:Seeking Alpha